Combined Serum Circulating Micro-RNA May Serve As Biomarker For Diagnosis Of NASH In Patients With NAFLD, Research Suggests

July 28, 2021

Healio (7/27, Burba) reports, “Combined serum circulating micro-RNA served as a novel biomarker for the diagnosis of nonalcoholic steatohepatitis [NASH] in patients with nonalcoholic fatty liver disease [NAFLD],” investigators concluded after analyzing “t...